Changes over time in risk factors for cardiovascular disease and use of lipid-lowering drugs in HIV-infected individuals and impact on myocardial infarction.
about
Angiotensin converting enzyme inhibitor and HMG-CoA reductase inhibitor as adjunct treatment for persons with HIV infection: a feasibility randomized trialChallenges in initiating antiretroviral therapy in 2010.Diabetes mellitus, preexisting coronary heart disease, and the risk of subsequent coronary heart disease events in patients infected with human immunodeficiency virus: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D Study).Risk of myocardial infarction in parents of HIV-infected Individuals: a population-based Cohort Study.Microbial translocation and cardiometabolic risk factors in HIV infection.The consequences of HIV infection and antiretroviral therapy use for cardiovascular disease risk: shifting paradigms.Comparative Effectiveness and Toxicity of Statins Among HIV-Infected PatientsCD4saurus Rex &HIVelociraptor vs. development of clinically useful immunological markers: a Jurassic tale of frozen evolutionDiabetes and cognitive decline in a French cohort of patients infected with HIV-1.Cardiovascular disease in HIV infection.Provider compliance with guidelines for management of cardiovascular risk in HIV-infected patients.Improvement in lipid profiles over 6 years of follow-up in adults with AIDS and immune reconstitutionImmune deficiency could be an early risk factor for altered insulin sensitivity in antiretroviral-naive HIV-1-infected patients: the ANRS COPANA cohort.Metabolic disorders and cardiovascular consequences of HIV infection and antiretroviral therapy.Cardiovascular Risk in HIV-Infected and Uninfected Postmenopausal Minority Women: Use of the Framingham Risk Score.High prevalence of physical inactivity among patients from the Swiss HIV Cohort Study.Interaction between enfuvirtide, an injectable fusion inhibitor, and niacin in an HIV-infected patient.Management of immunosuppression and antiviral treatment before and after heart transplant for HIV-associated dilated cardiomyopathy.Cohort profile: the Swiss HIV Cohort study.Cardiovascular disease (CVD) and chronic kidney disease (CKD) event rates in HIV-positive persons at high predicted CVD and CKD risk: A prospective analysis of the D:A:D observational study.Impact of NRTIs on lipid levels among a large HIV-infected cohort initiating antiretroviral therapy in clinical care.Effectiveness of n-3 fatty acids in the treatment of hypertriglyceridemia in HIV/AIDS patients: a meta-analysis.Changes in cardiovascular risk and clinical outcomes in a HIV/AIDS cohort study over a 1-year period at a specialized clinic in Mexico
P2860
Q28484460-9EF41B26-402C-4A14-A86E-6A058EE1F141Q30227046-277349CC-2B03-47AB-A170-7F5CDDE87D72Q33404972-4FB48835-C1F3-4E46-AC3D-CF7060910EF8Q33603728-EABC7949-FC73-4C04-8277-128DC2ABB8BDQ33713895-84921BC7-3FC3-4A0E-9BBB-22A2B749A577Q33889580-99768DC6-59F4-492C-8265-0FE1BDD15C1CQ35019859-FC5E5FA9-6301-49BA-B5A9-581609A4CC0EQ35121645-D8F8E6B5-E4F8-4735-A1D0-5B96110D49B3Q36155683-AEF98672-646A-4F08-AF5E-6BB2C1644098Q36408675-2312D5EA-E8DF-4BDD-90DD-9537BAA584DDQ36567732-8BED5A4A-8787-493E-BCC3-F53B29F07CE3Q37423288-F4633C5B-9F3F-44E7-AE42-5413C83173A6Q37485986-B7BE9FBA-1BA4-4E5D-BA3C-E45E00C78FA1Q37960180-483573AA-23BF-4DAA-9844-941D1C236EBDQ38950123-4F02BD6D-56A4-4F89-A7BC-EF2EF77BF5EEQ39040619-11ED891C-AF25-4253-AB1B-8F012B5426E0Q42838443-F5BC2745-AAD1-4F58-ABE9-3739A917D496Q43584691-EDAF8DE0-96B2-4358-B235-99E230A679E2Q46959264-B7466A71-4DC8-440D-9517-66172087BF04Q47134347-AF802726-DA0C-4A78-9A0B-DF4BE5E7C7CAQ51625767-85B1558F-38D1-48F0-9147-779897E13EA7Q51829297-9424C980-28A1-4622-993F-FD8F8FBF1088Q57070083-D6B0E9DC-60B3-4759-8E94-05A0CFF08957
P2860
Changes over time in risk factors for cardiovascular disease and use of lipid-lowering drugs in HIV-infected individuals and impact on myocardial infarction.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Changes over time in risk fact ...... pact on myocardial infarction.
@en
Changes over time in risk fact ...... pact on myocardial infarction.
@nl
type
label
Changes over time in risk fact ...... pact on myocardial infarction.
@en
Changes over time in risk fact ...... pact on myocardial infarction.
@nl
prefLabel
Changes over time in risk fact ...... pact on myocardial infarction.
@en
Changes over time in risk fact ...... pact on myocardial infarction.
@nl
P2093
P2860
P356
P1476
Changes over time in risk fact ...... pact on myocardial infarction.
@en
P2093
A N Phillips
A d'Arminio Monforte
Data Collection on Adverse Events of Anti-HIV Drugs Study Group
J D Lundgren
P2860
P304
P356
10.1086/528862
P407
P577
2008-04-01T00:00:00Z